2RN4

Solution structure of the alkaline proteinase inhibitor APRin from Pseudomonas aeruginosa

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-15N HSQC	0.8 mM [U-100% 15N] Alkaline Proteinase Inhibitor, 20 mM sodium phosphate, 100 mM potassium chloride	93% H2O/7% D2O	0.24	6.5	ambient	298
2	2D 1H-13C HSQC	1.7 mM [U-100% 13C; U-100% 15N] Alkaline Proteinase Inhibitor, 20 mM sodium phosphate, 100 mM potassium chloride	93% H2O/7% D2O	0.24	6.5	ambient	298
3	3D CBCA(CO)NH	1.7 mM [U-100% 13C; U-100% 15N] Alkaline Proteinase Inhibitor, 20 mM sodium phosphate, 100 mM potassium chloride	93% H2O/7% D2O	0.24	6.5	ambient	298
4	3D C(CO)NH	1.7 mM [U-100% 13C; U-100% 15N] Alkaline Proteinase Inhibitor, 20 mM sodium phosphate, 100 mM potassium chloride	93% H2O/7% D2O	0.24	6.5	ambient	298
5	3D HNCO	1.7 mM [U-100% 13C; U-100% 15N] Alkaline Proteinase Inhibitor, 20 mM sodium phosphate, 100 mM potassium chloride	93% H2O/7% D2O	0.24	6.5	ambient	298
6	3D HNCA	1.7 mM [U-100% 13C; U-100% 15N] Alkaline Proteinase Inhibitor, 20 mM sodium phosphate, 100 mM potassium chloride	93% H2O/7% D2O	0.24	6.5	ambient	298
7	3D HN(CO)CA	1.7 mM [U-100% 13C; U-100% 15N] Alkaline Proteinase Inhibitor, 20 mM sodium phosphate, 100 mM potassium chloride	93% H2O/7% D2O	0.24	6.5	ambient	298
8	3D HCCH-TOCSY	1.7 mM [U-100% 13C; U-100% 15N] Alkaline Proteinase Inhibitor, 20 mM sodium phosphate, 100 mM potassium chloride	93% H2O/7% D2O	0.24	6.5	ambient	298
9	3D H(CCO)NH	1.7 mM [U-100% 13C; U-100% 15N] Alkaline Proteinase Inhibitor, 20 mM sodium phosphate, 100 mM potassium chloride	93% H2O/7% D2O	0.24	6.5	ambient	298
10	3D HNHA	1.7 mM [U-100% 13C; U-100% 15N] Alkaline Proteinase Inhibitor, 20 mM sodium phosphate, 100 mM potassium chloride	93% H2O/7% D2O	0.24	6.5	ambient	298
11	3D 1H-15N NOESY	1.7 mM [U-100% 13C; U-100% 15N] Alkaline Proteinase Inhibitor, 20 mM sodium phosphate, 100 mM potassium chloride	93% H2O/7% D2O	0.24	6.5	ambient	298
12	3D 1H-15N TOCSY	1.7 mM [U-100% 13C; U-100% 15N] Alkaline Proteinase Inhibitor, 20 mM sodium phosphate, 100 mM potassium chloride	93% H2O/7% D2O	0.24	6.5	ambient	298
13	3D 1H-13C NOESY	1.7 mM [U-100% 13C; U-100% 15N] Alkaline Proteinase Inhibitor, 20 mM sodium phosphate, 100 mM potassium chloride	93% H2O/7% D2O	0.24	6.5	ambient	298
14	3D HCACO	1.7 mM [U-100% 13C; U-100% 15N] Alkaline Proteinase Inhibitor, 20 mM sodium phosphate, 100 mM potassium chloride	93% H2O/7% D2O	0.24	6.5	ambient	298
15	2D 1H-15N HSQC	0.6 mM [U-100% 13C; U-100% 15N] Alkaline Proteinase Inhibitor, 20 mM sodium phosphate, 100 mM potassium chloride	93% H2O/7% D2O	0.24	6.5	ambient	298

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Varian	INOVA	800

NMR Refinement
Method	Details	Software
DGSA-distance geometry simulated annealing, simulated annealing		CNS

NMR Ensemble Information
Conformer Selection Criteria	structures with the lowest energy
Conformers Calculated Total Number	100
Conformers Submitted Total Number	20
Representative Model	1 (lowest energy)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	processing	CNS	2.3-3.0	Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax
2	data analysis	CNS		Goddard
3	peak picking	CNS		Goddard
4	refinement	CNS	2.9.7

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.